News for hackers. Stuff that matters.
Re:‘Pharmacy of the developing world’ under attack from the ... by forrestthewoods on Tuesday August 25, 2015 @10:18AM (#10116626)
Of course they are. In the United States you also can't import cheap generic from Canada. Most intellectual property law is recognized and enforced internationally. Everyone on this board has a career because of IP law.

We have a globally broken system in that America subsidizes the world medicinally. American companies research and develop many (not all) drugs. Americans then pay out their asshole for those drugs. Other countries then get to make those drugs for "free". Not free free. But they get to ignore the R&D costs.

Eventually the camel's back will break. Research costs will become too high for 300m out of 7b to pay for. Then we can figure out a new system that works better. This is probably a good thing. I don't know what the system looks like though. No one does.

Re:‘Pharmacy of the developing world’ under attack from the ... by myth_buster on Tuesday August 25, 2015 @10:28AM (#10116699)

  Americans then pay out their asshole for those drugs. Other countries 
  then get to make those drugs for "free". Not free free. But they get to 
  ignore the R&D costs.

  Eventually the camel's back will break. Research costs will become too 
  high for 300m out of 7b to pay for.
This "Drug industry scare card" is easily refuted [0] (check the table).

  But as the table below shows, drug companies spend far more on 
  marketing drugs - in some cases twice as much - than on developing 
  them. And besides, profit margins take into account R&D costs.
[0] http://www.bbc.com/news/business-28212223
Re:‘Pharmacy of the developing world’ under attack from the ... by forrestthewoods on Tuesday August 25, 2015 @10:35AM (#10116765)
Few people dispute that it costs a billion dollars or so to bring a new drug to market. That's a heavy cost foreign manufacturers don't have to pay.

The fact that marketing is a higher spend is irrelevant. It's like free2play on mobile. You spend a bunch of money developing something. If you can spend $.90 in user acquisition to earn back $1.00 then you throw every single dollar you can muster so long as the benefit is higher than the cost. It's a diminishing returns equation so you do as long as you can. The highest grossing games have marketing campaigns on the order of $100,000,000. Basically the same thing here. Take out as many loans as you can so long as it works.

Re:‘Pharmacy of the developing world’ under attack from the ... by pavedwalden on Tuesday August 25, 2015 @10:56AM (#10116935)
I'm not saying you're wrong, but it struck me as funny to see a much-criticised practice in the pharmaceutical industry being defended by comparing it to F2P mobile games, which are also widely reviled.
Re:‘Pharmacy of the developing world’ under attack from the ... by forrestthewoods on Tuesday August 25, 2015 @11:13AM (#10117042)
Hah. I'm no fan of the f2p mobile gaming industry myself. But the math is very straight forward there. It exists for non-f2p games as well but it's less obvious and clear.
Re:‘Pharmacy of the developing world’ under attack from the ... by duaneb on Tuesday August 25, 2015 @10:59AM (#10116964)
I don't think they're questioning the business efficacy, I think they're questioning the need for protections for the industry.
Re:‘Pharmacy of the developing world’ under attack from the ... by tsotha on Tuesday August 25, 2015 @07:25PM (#10120120)
I don't see how Pharmaceutical companies can exist without IP protections, unless you're willing to publicly fund the entire development cycle.

For the vast majority of drugs the cost of producing the tablet you take is just a few cents, which is dwarfed by the amortized cost of the R&D. Nobody is going to spend on R&D if competitors can skip that part and go right to production.

Re:‘Pharmacy of the developing world’ under attack from the ... by duaneb on Wednesday August 26, 2015 @01:55PM (#10124812)
Drug research strikes me as exactly the type of industry that would benefit from optimizing for characteristic other than profits.
Re:‘Pharmacy of the developing world’ under attack from the ... by tsotha on Wednesday August 26, 2015 @05:57PM (#10126286)
Which makes it no different from any other industry. But the profit motive is the best we've come up with to get people to produce.
Re:‘Pharmacy of the developing world’ under attack from the ... by srean on Tuesday August 25, 2015 @01:05PM (#10117933)
Absolutely.

The main structural problem is the blanket protection from the market that the people/govt offer to the pharma companies. Many shills continue to argue that this is necessary for pharma to make progress.

The problem is that this a quantitative question -- how much protection in $$ should pharma companies receive that would still not get in the way of real progress? -- is given a blanket non-quantitative answer by fiat. The answer is neither known for certain nor a constant of nature, it changes with time and situation. Any mechanism addressing this problem should have a fast feedback loop and pretty much the only scalable mechanism that we have for such feedback on economic affairs is the market.

Rather than subverting the market, one should actively involve it to create an efficient market where the people/govt and the pharma companies negotiate the level of protection that they can both agree on.

Patents are a mechanism that largely nukes this negotiation completely in favor of the pharma companies.

A parting thought borrowed from Upton Sinclair : if the justification for patent protection is high dev costs, it only ensures that the dev costs will be kept high to enjoy the (dis-proportionate) protection.

Re:‘Pharmacy of the developing world’ under attack from the ... by jacobolus on Tuesday August 25, 2015 @10:24AM (#10116663)
American taxpayers fund most of the basic research through public grants to universities.

The pharmaceutical industry pays for clinical trials, marketing, and bribing doctors and government officials all over the world.

Re:‘Pharmacy of the developing world’ under attack from the ... by ekianjo on Tuesday August 25, 2015 @10:41AM (#10116814)
> The pharmaceutical industry pays for clinical trials, marketing, and bribing doctors and government officials all over the world.

Bribing goes both ways. Politicians and Doctors actively WANT to be bribed as well, let's not pretend they are victims.

Re:‘Pharmacy of the developing world’ under attack from the ... by emodendroket on Tuesday August 25, 2015 @10:29AM (#10116713)
Lots of programmings jobs could easily exist without any IP protection at all (if you're writing the server-side code for a Web-based product, nobody ever gets the opportunity to pirate the code) so you're going a little bit too far.
Re:‘Pharmacy of the developing world’ under attack from the ... by pavanky on Tuesday August 25, 2015 @10:28AM (#10116702)
Can you name some drugs whose IP has been immediately broken by other countries? From what I have read India is breaking IP laws for life saving medicines and / or trivial modifications to existing products.
Re:‘Pharmacy of the developing world’ under attack from the ... by PietdeVries on Tuesday August 25, 2015 @10:59AM (#10116959)
Then again, as long as the big pharmaceuticals still have a profit margin of 25% or so I don't think they are the victims here... Point is that there are two sides to this coin: the pharmaceuticals charging way too much for their medicine and the Indian companies copy-catting/piggy backing on the US R&D
Re:‘Pharmacy of the developing world’ under attack from the ... by presty on Tuesday August 25, 2015 @12:04PM (#10117416)
> Everyone on this board has a career because of IP law.

I don't know about that. I think more people here have a career thanks to open source. It has proven that it's a lot more effective than the barriers to knowledge.

Re:‘Pharmacy of the developing world’ under attack from the ... by J_Darnley on Tuesday August 25, 2015 @02:33PM (#10118598)
I think the stranger thing is that he thinks everyone here has a career or even works.